Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam + butorphanol sedation for painless gastroenteroscopy in elderly patients
ChiCTR2300070533Phase 4Not yet recruiting
- Sponsor
- Shunde Hospital, Southern Medical University
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and butorphanol in None (2 arms), sponsored by Shunde Hospital, Southern Medical University. Primary endpoint: ED95 of remimazolam + butorphanol. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
remimazolambutorphanol
Beyond the preview
Go deeper on ChiCTR2300070533.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070533.